MARKET

CHRO

CHRO

Channel Therapeutics Corporation
AMEX
1.120
+0.030
+2.75%
Closed 17:58 05/08 EDT
OPEN
1.150
PREV CLOSE
1.090
HIGH
1.150
LOW
1.090
VOLUME
63.09K
TURNOVER
0
52 WEEK HIGH
3.800
52 WEEK LOW
0.4500
MARKET CAP
6.84M
P/E (TTM)
-0.7848
1D
5D
1M
3M
1Y
5Y
1D
Pharma imports to U.S. surged in March ahead of tariffs, Reuters says
TipRanks · 2d ago
FDA announces expanded use of unannounced inspections at foreign facilities
TipRanks · 2d ago
Trump to sign order streamlining U.S. drug manufacturing regulations, WaPo says
TipRanks · 3d ago
Weekly Report: what happened at CHRO last week (0428-0502)?
Weekly Report · 3d ago
Chromocell Therapeutics Faces Going Concern Disclosure
TipRanks · 05/01 21:28
Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules
Barchart · 05/01 16:00
Roche price target lowered to CHF 220 from CHF 230 at JPMorgan
TipRanks · 04/30 18:15
J.P. Morgan Sticks to Its Sell Rating for Roche Holding AG (RHHVF)
TipRanks · 04/30 07:55
More
About CHRO
More
Channel Therapeutics Corporation is engaged in developing innovative, non-addictive, drugs to treat chronic neuropathic and acute and chronic eye pain. The Company is focused on the development of non-opioid pain treatment therapeutics with a focus on modulating NaV1.7 receptors responsible for sensing and transmitting pain in the peripheral nervous system. It is initially targeting orphan chronic pain indications, specifically small fiber neuropathy and erythromelalgia, and acute and chronic eye pain. The Company’s patented, selective, and potent (nM) inhibitor of human NaV1.7 has demonstrated additional efficacy in several models of pain: acute, chronic, inflammatory, visceral, post-surgical, and chemotherapy-induced.
Recently
Symbol
Price
%Change

Webull offers Channel Therapeutics Corp stock information, including AMEX: CHRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHRO stock methods without spending real money on the virtual paper trading platform.